Nihon Naika Gakkai Zasshi 2011-10-10

[Treatment of rheumatic diseases: current status and future prospective. Topics: II. Immunosuppressant/antirheumatic drugs; 5. Leflunomide and mizoribine].

Tetsuji Sawada

Index: Nippon. Naika Gakkai Zasshi. 100(10) , 2929-35, (2011)

Full Text: HTML

Abstract

Related Compounds

  • Leflunomide
  • Mizoribine

Related Articles:

Gingival pain: an unusual side effect of ziprasidone.

2013-01-01

[BMJ Case Rep. 2013 , doi:10.1136/bcr-2012-007577, (2013)]

An in vivo antilymphatic screen in zebrafish identifies novel inhibitors of mammalian lymphangiogenesis and lymphatic-mediated metastasis.

2014-10-01

[Mol. Cancer Ther. 13(10) , 2450-62, (2014)]

SND-117, a sinomenine bivalent alleviates type II collagen-induced arthritis in mice.

2015-06-01

[Int. Immunopharmacol. 26 , 423-31, (2015)]

miR-142-5p and miR-130a-3p are regulated by IL-4 and IL-13 and control profibrogenic macrophage program.

2015-01-01

[Nat. Commun. 6 , 8523, (2015)]

Methotrexate in combination with other DMARDs is not superior to methotrexate alone for remission induction with moderate-to-high-dose glucocorticoid bridging in early rheumatoid arthritis after 16 weeks of treatment: the CareRA trial.

2015-01-01

[Ann. Rheum. Dis. 74(1) , 27-34, (2015)]

More Articles...